UPDATE: Roth Capital Downgrades bluebird bio (BLUE) to Neutral

February 6, 2017 3:02 AM EST Send to a Friend
(Updated - February 6, 2017 8:55 AM EST)

Roth Capital downgraded bluebird bio (NASDAQ: BLUE) from Buy to Neutral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login